NYSE American - Delayed Quote USD

Scorpius Holdings, Inc. (SCPX)

0.0777 +0.0009 (+1.17%)
At close: May 15 at 4:00 PM EDT
0.0855 +0.01 (+10.04%)
After hours: May 15 at 7:59 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jeffrey Alan Wolf J.D. Founder, Chairman & CEO 575k -- 1963
Mr. William L. Ostrander CFO & Secretary 375k -- 1968
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. Chief Medical Advisor and Member of Scientific & Clinical Advisory Board -- -- --
Colonel George E. Peoples Jr., F.A.C.S., M.D. Chief Medical Advisor -- -- --
Ms. Ania Szymanska Site Head of Quality -- -- --
Mr. Joe Payne President & COO of Scorpius BioManufacturing -- -- --

Scorpius Holdings, Inc.

627 Davis Drive
Suite 400
Morrisville, NC 27560
United States
919 240 7133 https://www.scorpiusbiologics.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
82

Description

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Corporate Governance

Scorpius Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 15, 2024 - May 17, 2024
Scorpius Holdings, Inc. Earnings Call

Related Tickers

VAXX Vaxxinity, Inc.
0.0540
-10.00%
 
LYRA Lyra Therapeutics, Inc.
0.3558
-4.35%
 
AZTR Azitra, Inc.
0.1761
+0.11%
 
GLYC GlycoMimetics, Inc.
0.2700
-2.17%
 
TOVX Theriva Biologics, Inc.
0.3710
-0.80%
 
ALLR Allarity Therapeutics, Inc.
0.6801
-13.75%
 
FWBI First Wave BioPharma, Inc.
2.8300
-5.03%
 
RNAZ TransCode Therapeutics, Inc.
0.8066
+10.48%
 
TNXP Tonix Pharmaceuticals Holding Corp.
0.1826
+1.44%
 
PXMD PaxMedica, Inc.
0.2635
+27.29%